blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2233139

EP2233139 - Minoxidil aqueous composition containing bile acid [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.02.2018
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  17.03.2017
FormerGrant of patent is intended
Status updated on  10.02.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): CY, MK
published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
FUJIFILM Corporation
26-30, Nishiazabu 2-chome
Minato-ku
Tokyo 106-8620 / JP
[N/P]
Former [2017/13]For all designated states
FUJIFILM Corporation
26-30, Nishiazabu 2-chome Minato-ku
Tokyo 106-8620 / JP
Former [2010/39]For all designated states
FUJIFILM Corporation
26-30, Nishiazabu 2-chome Minato-ku
Tokyo 106-0031 / JP
Inventor(s)01 / Morita, Ritsuko
c/o FUJIFILM Corporation
577, Ushijima, Kaisei-machi
Ashigarakami-gun Kanagawa 258-8577 / JP
02 / Kanazawa, Katsuhiko
c/o FUJIFILM Corporation
798, Miyanodai, Kaisei-machi
Ashigarakami-gun Kanagawa 258-8538 / JP
 [2017/16]
Former [2010/39]01 / Morita, Ritsuko
c/o FUJIFILM Corporation 577, Ushijima, Kaisei-machi
Ashigarakami-gun Kanagawa 258-8577 / JP
02 / Kanazawa, Katsuhiko
c/o FUJIFILM Corporation 798, Miyanodai, Kaisei-machi
Ashigarakami-gun Kanagawa 258-8538 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/16]
Former [2010/39]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date10003003.022.03.2010
[2010/39]
Priority number, dateJP2009006988723.03.2009         Original published format: JP 2009069887
[2010/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2233139
Date:29.09.2010
Language:EN
[2010/39]
Type: B1 Patent specification 
No.:EP2233139
Date:19.04.2017
Language:EN
[2017/16]
Search report(s)(Supplementary) European search report - dispatched on:EP24.06.2010
ClassificationIPC:A61K31/506, A61K47/12, A61K47/42, A61K9/00
[2010/39]
CPC:
A61K8/4953 (EP,US); A61K31/506 (EP,US); A61K31/575 (EP,US);
A61K45/06 (EP,US); A61K8/63 (EP,US); A61K9/0014 (EP,US);
A61P17/14 (EP); A61P9/12 (EP); A61Q5/02 (EP,US);
A61Q7/00 (EP,US); A61K9/10 (EP,US) (-)
C-Set:
A61K31/506, A61K2300/00 (EP,US);
A61K31/575, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/16]
Former [2010/39]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Wässrige Minoxidil-Zusammensetzung, die Gallensäure enthält[2010/39]
English:Minoxidil aqueous composition containing bile acid[2010/39]
French:Composition aqueuse de minoxydil contenant de l'acide biliaire[2010/39]
Examination procedure28.03.2011Amendment by applicant (claims and/or description)
29.03.2011Examination requested  [2011/19]
27.11.2015Despatch of a communication from the examining division (Time limit: M04)
17.02.2016Reply to a communication from the examining division
29.09.2016Communication of intention to grant the patent
03.02.2017Fee for grant paid
03.02.2017Fee for publishing/printing paid
03.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.11.2015
Opposition(s)22.01.2018No opposition filed within time limit [2018/13]
Fees paidRenewal fee
15.03.2012Renewal fee patent year 03
20.03.2013Renewal fee patent year 04
18.03.2014Renewal fee patent year 05
10.03.2015Renewal fee patent year 06
10.03.2016Renewal fee patent year 07
10.03.2017Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.03.2010
AT19.04.2017
CY19.04.2017
CZ19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
IT19.04.2017
LT19.04.2017
LV19.04.2017
MC19.04.2017
MK19.04.2017
NL19.04.2017
PL19.04.2017
PT19.04.2017
RO19.04.2017
SE19.04.2017
SI19.04.2017
SK19.04.2017
SM19.04.2017
TR19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
[2020/31]
Former [2020/27]HU22.03.2010
AT19.04.2017
CZ19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
IT19.04.2017
LT19.04.2017
LV19.04.2017
MC19.04.2017
NL19.04.2017
PL19.04.2017
PT19.04.2017
RO19.04.2017
SE19.04.2017
SI19.04.2017
SK19.04.2017
SM19.04.2017
TR19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2020/15]AT19.04.2017
CZ19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
IT19.04.2017
LT19.04.2017
LV19.04.2017
MC19.04.2017
NL19.04.2017
PL19.04.2017
RO19.04.2017
SE19.04.2017
SI19.04.2017
SK19.04.2017
SM19.04.2017
TR19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2018/52]AT19.04.2017
CZ19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
IT19.04.2017
LT19.04.2017
LV19.04.2017
MC19.04.2017
NL19.04.2017
PL19.04.2017
RO19.04.2017
SE19.04.2017
SI19.04.2017
SK19.04.2017
SM19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2018/25]AT19.04.2017
CZ19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
IT19.04.2017
LT19.04.2017
LV19.04.2017
NL19.04.2017
PL19.04.2017
RO19.04.2017
SE19.04.2017
SI19.04.2017
SK19.04.2017
SM19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2018/11]AT19.04.2017
CZ19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
IT19.04.2017
LT19.04.2017
LV19.04.2017
NL19.04.2017
PL19.04.2017
RO19.04.2017
SE19.04.2017
SK19.04.2017
SM19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2018/10]AT19.04.2017
CZ19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
LT19.04.2017
LV19.04.2017
NL19.04.2017
PL19.04.2017
RO19.04.2017
SE19.04.2017
SK19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2018/09]AT19.04.2017
DK19.04.2017
EE19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
LT19.04.2017
LV19.04.2017
NL19.04.2017
PL19.04.2017
SE19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2017/50]AT19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
LT19.04.2017
LV19.04.2017
NL19.04.2017
PL19.04.2017
SE19.04.2017
BG19.07.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2017/49]AT19.04.2017
ES19.04.2017
FI19.04.2017
HR19.04.2017
LT19.04.2017
NL19.04.2017
NO19.07.2017
GR20.07.2017
IS19.08.2017
Former [2017/48]NL19.04.2017
Documents cited:Search[XY]WO9953923  (SOLTEC RES PTY LTD [AU], et al) [X] 1,2,10 * page 2, line 23 * * page 5, lines 3-8 * * example 1 * [Y] 3-5,9;
 [X]US2002031558  (YOO SEO HONG [US]) [X] 1,3,9,10 * abstract * * paragraphs [0034] , [0045] * * paragraph [0066] * * paragraph [0089] * * claims 1,48,52 *;
 [Y]WO2006057637  (YOO SEO HONG [US]) [Y] 1-10 * the whole document *;
 [Y]WO2007074476  (DABUR PHARMA LTD [IN], et al) [Y] 1-10 * page 17, lines 11,12 * * claims 66,68,74 * * page 38, lines 24,25 * * page 39, lines 3-6 *
ExaminationUS5030442
by applicantUS3461461
 US4139619
 US4596812
 JPH1174355
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.